Healthcare Industry News: HSMN NewsFeed
News Release - May 10, 2017
Bioness and Ottobock Announce Strategic European Distribution PartnershipCapitalizing on the strengths of each organization this synergistic partnership will expand technology access across Europe and beyond
VALENCIA, Calif. and DUDERSTADT, Germany, May 10, 2017 -- (Healthcare Sales & Marketing Network) -- Bioness and Ottobock together are partnering to expand distribution and access of functional electrical stimulation (FES) technologies in the European Union, UK, Switzerland, Norway, Turkey and India. The collaboration will combine best-in-class technologies and resources to transform the mobility management paradigm, deliver next-generation medical solutions and expand product reach while improving the user experience.
"Our partnership with Ottobock opens up significant opportunity for both organizations," said Todd Cushman, President & CEO of Bioness. "Our leading technology position in functional electrical stimulation, highlighted by the recent clearance of the L300 Go™ System by US FDA and CE Mark, combined with Ottobock's resources, reputation and market reach, creates an extremely powerful synergy."
"Since 2005 Ottobock has been offering functional electrical stimulation device solutions as part of their mobility after stroke concept for healthcare providers and patients," said Frank Bömers, Global Head of Orthotics for Ottobock. "Our strategic partnership with Bioness reinforces our commitment to the technology platform and allows Ottobock to leverage our resources to expand product access and affordability."
Ottobock will begin product commercialization within its Orthotics Division starting September 2017 and distribute Bioness' complete FES portfolio for the lower (L300 Go System) and upper extremities (H200 Wireless® System). Bioness and Ottobock are committed to a smooth and successful transition. Bioness and Ottobock share many mutual customers; this strategic partnership will enable both organizations to improve technology access as well as enhance the healthcare provider and patient experience.
About Bioness, Inc.
Bioness provides innovative medical solutions to important patient populations including those with chronic pain and limb paralysis. Bioness solutions include neuromodulation systems, robotic systems and software-based therapy programs which provide functional and therapeutic benefits for individuals affected by pain, central nervous system disorders and orthopedic injuries.
Ottobock uses innovative technology, superior service, and world-class education to help people with physical mobility challenges. Established in 1919 in Germany, Ottobock opened its doors in the U.S. in 1958 and in Canada in 1978. Currently in its third generation as a privately held company, Ottobock offers products and services to help people maintain or regain their freedom of movement.
L300 Go™, H200 Wireless®, Bioness, the Bioness Logo® are trademarks of Bioness, Inc. Ottobock®, the Ottobock Logo® are trademarks of Ottobock.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsBioness Receives FDA Clearance for myBioness(TM) iOS app for mobile control of the L300 Go(TM) System
New Medical Policy Makes the Bioness StimRouter(R) Neuromodulation System a Covered Benefit for Highmark Blue Cross Blue Shield Policy Holders
Bioness Receives Health Canada Approval for StimRouter Neuromodulation System